This cross-sectional study examines shifts in health industry entry and sector choice among women, racially minoritized workers, and immigrants during the pandemic era. Using data from the Annual Social and Economic Supplement of the Current Population Survey (2018-2023), we compare entrant characteristics before and during the pandemic era, focusing on demographic composition and sector choice. Results show minimal shifts by gender, race, or education but highlight a rise in entrants from outside the labor force, particularly among White women and racially minoritized men. There were changes in sector choice: ambulatory care saw the greatest increase in racially minoritized entrants, with small increases for hospitals and a decrease for long-term care. Despite these sector-specific shifts, overall opportunities for minoritized workers did not expand, nor did workforce diversity significantly improve. These findings underscore the need for research that examines how policies outside the workplace shape worker behavior, particularly among marginalized groups.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/10775587251320684 | DOI Listing |
Med Care Res Rev
March 2025
University of Washington, Seattle, USA.
This cross-sectional study examines shifts in health industry entry and sector choice among women, racially minoritized workers, and immigrants during the pandemic era. Using data from the Annual Social and Economic Supplement of the Current Population Survey (2018-2023), we compare entrant characteristics before and during the pandemic era, focusing on demographic composition and sector choice. Results show minimal shifts by gender, race, or education but highlight a rise in entrants from outside the labor force, particularly among White women and racially minoritized men.
View Article and Find Full Text PDFExpert Rev Pharmacoecon Outcomes Res
March 2025
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, Washington, USA.
Introduction: In a previous publication, we provided an overview of the current situation of patient access to orphan drugs in the European Union (EU), of the evolving rare disease policy landscape and recommendations for areas of improvement throughout the lifecycle of orphan drugs. This article aims to provide an update on evolving new policies impacting access to orphan drugs in the European Union from a health technology developers perspective.
Areas Covered: We provide an update of the emerging competitiveness gap in the pharmaceutical sector between the EU and the United States.
Cureus
February 2025
Health Adminstration, King Saud University, Riyadh, SAU.
Background And Aim: To address healthcare challenges in Saudi Arabia, such as quality, efficiency, and increasing healthcare demands, the healthcare sector is undergoing significant transformation under the Healthcare Transformation Program in both public and private sectors, aligned with Vision 2030 for the country. The aim of this study was to investigate the factors influencing the preference of patients between public and private hospitals in Riyadh, Saudi Arabia.
Methods: This was a descriptive cross-sectional study.
BMC Med Educ
March 2025
Department of Medical Education, Poznan University of Medical Sciences, 7 Rokietnicka St, Poznan, 60-806, Poland.
Background: The existing staff shortages and growing worldwide demand call for action to increase the number of practicing nurses. Following the identified gap in the literature, this qualitative study aims to analyze what motivated nursing students to choose nursing as their field of study and whether they still plan to pursue it after graduation, including the factors influencing their intentions.
Methods: Thirty semi-structured interviews were conducted with nursing students from Poznan University of Medical Sciences (Poland) on this matter, and the obtained data were subjected to thematic analysis performed by two researchers.
Pharmacoeconomics
March 2025
Centre for Health Economics, Alcuin a Block, University of York, York, YO10 5DD, UK.
Background And Objective: Economic evaluation of antimicrobial resistance (AMR) interventions is complicated by the multisectoral, inter-temporal and international aspects of the problem, further hindered by a lack of available data and theoretical understanding of the emergence and transmission of AMR. Despite the substantial global focus on the problem, there is a lack of comprehensive economic evaluation literature on AMR policies. The goal of this work is to review the available literature on the economic evaluation of AMR interventions focusing on methods used to quantify the effects on AMR and the associated health consequences and costs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!